Ondansetron HCL 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3SAT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,024
Award facts
- Contract value 100% obligated
- $11,023.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,023.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron HCL 8 MG, an antiemetic medication commonly used in military and federal healthcare settings. The contract, issued on December 19, 2025, with completion targeted for December 22, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The company's comprehensive SPE2DX vehicle enables supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. This delivery order exemplifies the company's role in providing essential medications through the competitive, firm fixed-price delivery order mechanism that characterizes DLA's pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DR26F3SAT?
SPE2DR26F3SAT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F3SAT worth?
The government has obligated $11,024 on SPE2DR26F3SAT.
Is contract SPE2DR26F3SAT an order under another contract?
Yes. SPE2DR26F3SAT is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3SAT competed?
The extent of competition for SPE2DR26F3SAT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award